Bluetongue virus: Past, present, and future scope.

Bluetongue (BT), once considered a disease of sheep confined to the southern African region, has spread all over the world. BT is a viral disease caused by the bluetongue virus (BTV). BT is regarded as an economically important disease in ruminants of compulsory notification to OIE. BTV is transmitted by the bite of Culicoides species. Research over the years has led to a better understanding of the disease, the nature of the virus life cycle between ruminants and Culicoides species, and its distribution in different geographical regions. Advances have also been made in understanding the molecular structure and function of the virus, the biology of the Culicoides species, its ability to transmit the disease, and the persistence of the virus inside the Culicoides and the mammalian hosts. Global climate change has enabled the colonization of new habitats and the spread of the virus into additional species of the Culicoides vector. This review highlights some of the current findings on the status of BT in the world based on the latest research on disease aspects, virus-host-vector interactions, and the different diagnostic approaches and control strategies available for BTV.

A decade of research on Bluetongue virus in Andhra Pradesh, a Southern state of India.

High sheep population density, congenial climatic conditions for Culicoides propagation, and susceptible sheep breeds may be contributing to the higher incidence of Bluetongue (BT) in Southern states of India. Sheep farming in this part of the country is nomadic in nature and BT is one of the major infectious diseases inflicting huge losses. Andhra Pradesh is one of the Southern states with high sheep population in India. Although isolation studies in this region were started in 1993, concerted efforts only began in 2002. More than 50 isolates were obtained in the last decade, and 7 Bluetongue virus (BTV) serotypes (1, 2, 9, 10, 12, 16 and 21) were isolated. Among them, BTV-10, BTV-12, and BTV-21 were reported for the first time from India and the genome analysis of these viruses revealed that BTV-10 and BTV-12 have high sequence identity with the modified live virus (MLV) vaccines used in USA and South Africa, respectively. At the same time, BTV-21 has probably originated from Southeast Asia. Furthermore, some of the BTV isolated from Europe have high sequence identity with viruses isolated from Andhra Pradesh indicating common ancestry. The analysis of different isolates involved in outbreaks revealed that more than 1 BTV serotype is involved and that mixed infections with different serotypes is not uncommon. In a limited study conducted during 2005-2009, it was observed that most of the sheep seroconverted to more than 1 serotype, which further supports circulation of multiple serotypes and mixed infections in Andhra Pradesh. Based on the virus isolation data, in this study it was observed that a few serotypes dominate for 3-4 years followed by domination of others. Continuous monitoring of circulating serotypes is essential to understand the distribution and spread BTV in endemic areas and for devising suitable control measures.

Genome Sequence of Bluetongue Virus Type 2 from India: Evidence for Reassortment between Outer Capsid Protein Genes.

Southern Indian isolate IND1994/01 of bluetongue virus serotype 2 (BTV-2), from the Orbivirus Reference Collection at the Pirbright Institute (http://www.reoviridae.org/dsRNA_virus_proteins/ReoID/btv-2.htm#IND1994/01), was sequenced. Its genome segment 6 (Seg-6) [encoding VP5(OCP2)] is identical to that of the Indian BTV-1 isolate (IND2003/05), while Seg-5 and Seg-9 are closely related to isolates from South Africa and the United States, respectively.

Comparison of bluetongue virus detection and quantitation methods in south India.

INTRODUCTION: Bluetongue (BT), a vector-borne viral disease, primarily affects sheep. Of the 26 serotypes of BTV identified so far, 22 are reported to be circulating in India. Due to an increase in vector population and delays in disease diagnosis, the BT control program heavily relies on rapid and confirmatory diagnosis. Polymerase chain reaction (PCR)-based real-time detection assays may be an ideal method to detect the BTV genome in animal blood at an early stage of infection. METHODOLOGY: In this study, a SYBR green-based real-time RT-PCR assay was evaluated, validated, and compared with conventional RT-PCR. The specificity and sensitivity of an assay using BTV-2 RNA extracted from tenfold serially diluted (starting from 1.0 TCID50/mL) cell culture virus was also evaluated. RESULTS: While conventional RT-PCR could detect 3.16 × 10(2) TCID50 of virus/mL, the real-time PCR test had a detection limit of 3.16 × 10(-4) TCID50/mL. Melting curve analysis indicated the absence of non-specific amplification (R(2) = 0.987). Out of the 32 infected blood samples examined, 24 tested positive for BTV RNA. Seven that were found negative through conventional PCR tested positive through real-time PCR. CONCLUSIONS: These results showed that the SYBR green-based real-time PCR assay is rapid, sensitive, and equally specific in the diagnosis of BT in BTV-affected animals.